CNS & Neurological Disorders - Drug Targets
Title:Preface
Volume: 16 Issue: 1
Author(s): Stephen D. Skaper
Affiliation:
Export Options
About this article
Cite this article as:
Skaper D. Stephen, Preface, CNS & Neurological Disorders - Drug Targets 2017; 16 (1) . https://dx.doi.org/10.2174/187152731601170111213937
DOI https://dx.doi.org/10.2174/187152731601170111213937 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dependence of Cell Survival on Correlative Activities of Xanthine Oxidase and Dihydopyrimidine Dehydrogenase in Human Brain-Derived Cell Culture
Central Nervous System Agents in Medicinal Chemistry Antioxidant Pathways in Alzheimers Disease: Possibilities of Intervention
Current Pharmaceutical Design Neuropeptides, Neuropeptidases and Brain Asymmetry
Current Protein & Peptide Science Design, Synthesis and Evaluation of Dual-targeting Prodrug Co-modified by Organic Amine and L-ascorbic Acid for CNS Delivery
Letters in Drug Design & Discovery Editorial [Hot Topic: Conformational Diseases (Guest Editor: Paolo Zatta)]
Current Alzheimer Research Machine Learning Study of Classifiers Trained with Biophysiochemical Properties of Amino Acids to Predict Fibril Forming Peptide Motifs
Protein & Peptide Letters Xanthine Oxidase and Transforming Growth Factor Beta-activated Kinase 1: Potential Targets for Gout Intervention
Current Rheumatology Reviews Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Targeting Rho GTPases by Peptidic Structures
Current Pharmaceutical Design Identification of Structural and Electronic Features for a Series of MCH1R Antagonists
Medicinal Chemistry Flavonoids as Multi-Target Compounds in Drug Discovery
Mini-Reviews in Organic Chemistry Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy
Letters in Drug Design & Discovery Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Progression of Alzheimer Disease in Europe: Data from the European ICTUS Study
Current Alzheimer Research Detoxification Depot for β -Amyloid Peptides
Current Alzheimer Research Dutasteride in Androgenetic Alopecia: An Update
Current Clinical Pharmacology Nerve Growth Factor, Stress and Diseases
Current Medicinal Chemistry Does A Subclinical Cardiotoxic Effect of Clozapine Exist? Results from a Follow-up Pilot Study
Cardiovascular & Hematological Agents in Medicinal Chemistry Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design Biomarkers as a Guide of Medical Treatment in Cardiovascular Diseases
Current Medicinal Chemistry